| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/28/1999 | WO1999003837A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 01/28/1999 | WO1999003828A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/28/1999 | WO1999003461A1 Oily patches for external use containing diclofenac sodium |
| 01/28/1999 | WO1999003446A2 Antimicrobial cosmetic compositions |
| 01/28/1999 | WO1999003365A1 Nutritional composition containing methionine |
| 01/28/1999 | WO1998046632A3 Inhibitors for urokinase receptor |
| 01/28/1999 | DE19731571A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 01/28/1999 | CA2297436A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these |
| 01/28/1999 | CA2296145A1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain |
| 01/28/1999 | CA2295021A1 2-substituted imidazoles useful in the treatment of inflammatory diseases |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892795A1 Piperidinylpyramidine derivatives |
| 01/27/1999 | EP0892794A1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892784A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents |
| 01/27/1999 | EP0892642A1 Use in a composition of an extract of at least one labiate |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1041830C Peptide compound |
| 01/26/1999 | US5864037 Dethionating, halogenating and aminating a 2-thiocarbonyl-6-oxo-3,8-disubstituted-1,2,3,6-tetrahydro-3h-purine to obtain the 6-amino derivative; bronchodilators; antiinflammatory agents |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5864028 Degradation resistant mRNA derivatives linked to TNF-α ribozymes |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863786 Nucleic acid encoding modified human tnfα (tumor necrosis factor alpha) receptor |
| 01/26/1999 | US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863560 Compositions and methods for topical application of therapeutic agents |
| 01/26/1999 | US5863535 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002528A1 Novel compounds |
| 01/21/1999 | WO1999002527A1 Naphthyridine derivatives |
| 01/21/1999 | WO1999002523A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/21/1999 | WO1999002510A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | WO1999002505A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | WO1999002501A1 Novel compounds |
| 01/21/1999 | WO1999002500A1 Resolution of amines |
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | WO1999002181A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 01/21/1999 | WO1999002172A1 PHARMACEUTICAL FORMULATIONS COMPRISING VEGETAL MATERIAL SELECTED FROM $i(TRICHILIA) |
| 01/21/1999 | WO1999002166A1 Use of colchinol derivatives as vascular damaging agents |
| 01/21/1999 | WO1999002163A1 Inhibitors of neutrophil mediated oxidant production |
| 01/21/1999 | WO1999002149A1 Use of petroselinum acid for treating inflammations |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2296581A1 Use of hyaluronidase in the manufacturing of a drug for the treatment of inflammation |
| 01/21/1999 | CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | CA2295800A1 Resolution of amines |
| 01/21/1999 | CA2295697A1 Inhibitors of neutrophil mediated oxidant production |
| 01/21/1999 | CA2295626A1 Novel compounds |
| 01/21/1999 | CA2295622A1 Pharmaceutical formulations comprising vegetal material selected from trichilia |
| 01/21/1999 | CA2295598A1 Naphthyridine derivatives |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2294817A1 Use of petroselinum acid for treating inflammations |
| 01/21/1999 | CA2294145A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | CA2265671A1 Matrix metalloproteinase inhibitors |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891719A1 Nutritional composition containing methionine |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891422A1 Complex superoxide dismutase product |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | EP0891346A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 01/20/1999 | EP0891345A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0674624B1 Pyrazoles having crf antagonist activity |
| 01/20/1999 | EP0630245B1 Protein kinase c inhibitor |
| 01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/20/1999 | CN1205641A Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs |
| 01/20/1999 | CN1205631A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205630A Transdermal device for delivery of flurbiprofen |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/20/1999 | CN1205222A Medicinal liquor for treating rheumatism and atrophic arthritis |
| 01/20/1999 | CN1041720C Bicyclic amide derivatives, its prepn. method, medicinal compsns. and medical application |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861433 Prevention and improvement of inflammation caused by leucotriene B4 |
| 01/19/1999 | US5861426 Nitro esters of aromatic compounds with amide or ester groups |
| 01/19/1999 | US5861412 Dihydro-isoquinoline compounds and their use as pharmaceuticals |
| 01/19/1999 | US5861404 2,9-disubstituted purin-6-ones |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/19/1999 | US5861375 Compounds for treatment of malaria, toxoplasmosis and coccidiosis |